Breaking News: Therma Bright Expands Venowave Distribution in the U.S. with DME Authority!
Initiative Includes Milestone-Based Inventory Purchase Commitments During Q1 and Q2, 2025
Toronto, Ontario–(Newsfile Corp. – December 18, 2024) –
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) (“Therma” or the “Company”), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce the Company has signed a letter of intent (LOI) for a Venowave distribution program with DME Authority based in Nashville, TN. Through this distribution program, DME Authority will collaborate with multiple tenured and qualified network partners to establish no less than three (3) comprehensive U.S. distribution agreements.
Therma Bright’s expansion of Venowave distribution in the U.S. through the partnership with DME Authority marks a significant milestone for the Company. With milestone-based inventory purchase commitments during the first and second quarters of 2025, Therma is poised to increase its market presence and reach a wider customer base in the U.S. market.
The collaboration with DME Authority, a reputable distributor in the medical equipment industry, will enable Therma Bright to leverage its innovative technologies and expertise in medical devices to provide advanced diagnostic solutions to individuals in need of effective healthcare treatments. The comprehensive distribution agreements established through this initiative will not only benefit Therma Bright and DME Authority but also contribute to improving healthcare accessibility and quality for patients across the United States.
Impact on Individuals
As an individual, the expansion of Venowave distribution in the U.S. with DME Authority will have a positive impact on access to innovative medical technologies and advanced diagnostic solutions. Patients in need of effective healthcare treatments will benefit from the increased availability of Therma Bright’s products through the comprehensive distribution agreements established with DME Authority. This collaboration will contribute to improving healthcare accessibility and quality, ultimately enhancing the overall patient experience and outcomes.
Impact on the World
The expansion of Venowave distribution in the U.S. with DME Authority signifies a significant step towards advancing healthcare technology and improving patient care on a global scale. By leveraging innovative diagnostic solutions and medical device technologies, Therma Bright and DME Authority are setting a precedent for enhancing healthcare accessibility and quality worldwide. This initiative has the potential to drive positive change in the medical equipment industry and set new standards for healthcare delivery and patient outcomes around the world.
Conclusion
In conclusion, the news of Therma Bright expanding Venowave distribution in the U.S. with DME Authority signifies a major milestone for the Company and the healthcare industry as a whole. The partnership with DME Authority and the establishment of comprehensive distribution agreements will not only benefit Therma Bright’s market presence but also contribute to improving healthcare accessibility and quality for individuals in need of effective medical solutions. This initiative has the potential to drive positive change and set new standards for healthcare delivery and patient outcomes, both at an individual level and on a global scale.
